Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025)

Indivior Pharmaceuticals' (INDV) quarterly Exchange Rate Effect came in at -$2.0 million in Q3 2025, down 100.0% year-on-year from -$inf billion in Q3 2024, and down 300.0% quarter-over-quarter from $1.0 million in Q2 2025.

Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025) Analysis & Trends

Indivior Pharmaceuticals' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$2.0 million for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect fell 100.0% year-over-year to -$2.0 million in Q3 2025; TTM through Mar 2026 was -$1.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.0 million, changed N/A from the prior year.
  • Exchange Rate Effect fell to -$2.0 million in Q3 2025 per INDV's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.0 million in Q4 2024 and bottomed at -$2.0 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -17.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 17.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.01 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -4.20 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -5.00 Mn
10 Indivior Pharmaceuticals 1.00 Bn 829.65 Mn 277.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -2.00 Mn
Sep 30, 2025 -2.00 Mn
Jun 30, 2025 1.00 Mn
Jun 30, 2025 1.00 Mn
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 -1.00 Mn
Sep 30, 2024 -1.00 Mn